Osteoarthritis Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Osteoarthritis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Osteoarthritis Market Size During the Forecast Period?
The market for osteoarthritis has seen significant expansion in the recent past. It's projected to increase from $6.87 billion in 2024 to $7.53 billion in 2025, witnessing a compound annual growth rate (CAGR) of 9.6%. The historical growth has been fueled by factors such as the aging population, rising obesity levels, improvements in imaging technology, and pain management advancements.

Anticipated robust expansion is predicted for the osteoarthritis market in the forthcoming years. It's projected to swell to a value of $10.64 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%. Factors such as non-pharmacological strategies, disease-altering osteoarthritis medications (dmoads), personalized medicine, telehealth and remote patient monitoring, are contributing to this expected growth in the forecast span. Looking ahead, regenerative therapy, wearable tech, artificial intelligence for diagnosis, and digital health tools are likely to be prominent trends during the forecast period.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

What Are the High-Growth Segments in the Osteoarthritis Market?
The osteoarthritis market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Therapy
2) By Diagnosis: Imaging, Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Medical Institutes

Subsegments:
1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion
3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Key Drivers Are Expected to Influence Future Osteoarthritis Market Growth?
The escalating cases of obesity-linked disorders are anticipated to stimulate the osteoarthritis market's progression. Disorders connected to obesity encompass a variety of health complications resulting from surplus body fat. This happens when the body takes in more calories than it utilizes via physical activities and exercises, excessive intake of processed or fast food, or excessive alcohol consumption. Obesity can trigger osteoarthritis by creating stress on joints, igniting inflammation as well as fluctuating hormones and thus, enhancing the burden on the joints. For example, the World Obesity Atlas 2022, published by the World Obesity Federation, a non-profit entity from the UK, suggests that by 2030, 1 billion people globally, which includes 1 out of 7 men and 1 out of 5 women, will be obese. And by 2035, this figure will rise to 4 billion people or 51% of the global population, living either overweight or obese. Hence, the escalating obesity-related disorders are fueling the progression of the osteoarthritis market. The broad application of painkillers is projected to invigorate the growth of the osteoarthritis market. Painkillers are medicines or compounds utilized to diminish pain. They function by lessening the sensation of pain and can aid symptomatic relief in various conditions or injuries. The extensive utilization of painkillers for managing osteoarthritis, propelled by the requirement for effective pain alleviation, can significantly affect the osteoarthritis market. It can enhance demand, influence treatment protocols, accelerate research and development initiatives, and heighten awareness about the condition. For instance, according to the Consumer Healthcare Products Association, a trade association based in the US, in June 2022, nearly 80% of respondents stated that their use of over-the-counter pain relievers has either remained constant (49%) or increased (30%) over the past two years. Hence, the broad application of painkillers is boosting the osteoarthritis market's growth.

Which Companies Hold the Largest Share Across Different Osteoarthritis Market Segments?
Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

What Trends Are Driving Growth in The Osteoarthritis Market?
Key players in the osteoarthritis market are resorting to strategic collaborations to amplify technological incorporation and broaden their market presence. Such partnerships generally involve two or more companies pooling their resources, knowledge, and energy to achieve shared goals or targets. For instance, in July 2024, LG Chem, a pharmaceutical firm based in South Korea, formed a partnership with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and manufacturing firm based in China. This partnership was aimed to launch Synovian, an osteoarthritis injection in the Chinese market, which possesses similar healing impacts as traditional multiple-dose formulations, but with a single dose. Synovian's unique aspects comprise its high molecular weight hyaluronic acid (10 million Dalton), which boosts viscoelasticity and joint functionality, and its proven potential to notably lessen knee pain as per clinical phase 3 trial outcomes. Such developments position Synovian as an efficient solution for patients looking for handy relief from osteoarthritis symptoms.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

What Are the Emerging Geographies for The Osteoarthritis Market Growth?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Osteoarthritis Market?
2. What is the CAGR expected in the Osteoarthritis Market?
3. What Are the Key Innovations Transforming the Osteoarthritis Industry?
4. Which Region Is Leading the Osteoarthritis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.